Identification and characterization of the Hesr1/Hey1 as a candidate trans-acting factor on gene expression through the 3′ non-coding polymorphic region of the human dopamine transporter (DAT1) gene

Journal of Biochemistry

Volumn 137, Issue 2, 2005, Pages 205-216

  Fuke, Satoshi ^a   Sasagawa, Noboru ^a   Ishiura, Shoichi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Behavioral traits; Polygenic disorder; Polymorphism; SNP; VNTR

Indexed keywords

DOPAMINE; DOPAMINE TRANSPORTER; DOPAMINE TRANSPORTER 1; HAIRY ENHANCER OF SPLIT RELATED TRANSCRIPTION FACTOR 1; HELIX LOOP HELIX PROTEIN; PROTEIN HEY1; TRANS ACTING FACTOR; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BEHAVIOR; CELL LINE; CONTROLLED STUDY; DAT1 GENE; DOPAMINERGIC TRANSMISSION; DOWN REGULATION; EMBRYO; GENE; GENE ACTIVITY; GENE EXPRESSION REGULATION; GENETIC DISORDER; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; MAMMAL CELL; MENTAL DISEASE; MOUSE; MULTIFACTORIAL INHERITANCE; NEUROLOGIC DISEASE; NONHUMAN; PROTEIN FUNCTION; PROTEIN MOTIF; SINGLE NUCLEOTIDE POLYMORPHISM; TANDEM REPEAT;

3' FLANKING REGION; ALLELES; ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL CYCLE PROTEINS; CELLS, CULTURED; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOWN-REGULATION; GENE EXPRESSION; GENE FREQUENCY; GENES, REPORTER; HUMANS; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MINISATELLITE REPEATS; MOLECULAR SEQUENCE DATA; NERVE TISSUE PROTEINS; POLYMORPHISM, GENETIC; SEQUENCE DELETION; TRANSCRIPTION FACTORS;

EID: 17044423443     PISSN: 0021924X     EISSN: None     Source Type: Journal    
DOI: 10.1093/jb/mvi020     Document Type: Article

References (59)

1. Bannon, M.J., Michelhaugh, S.K., Wang, J., and Sacchetti, P. (2001) The human dopamine transporter gene: gene organization, transcriptional regulation, and potential involvement in neuropsychiatric disorder. Eur. Neuropsychopharmacol. 11, 449-455
2. Uhl, G.R. (2003) Dopamine transporter: Basic science and human variation of a key molecule for dopaminergic function, locomotion, and Parkinsonism. Mov. Disord. 18, 71-80
3. Giros, B., el Mestikawy, S., Bertrand, L., and Caron, M.G. (1991) Cloning and functional characterization of a cocaine-sensitive dopamine transporter. FEBS Lett. 295, 149-154
4. Kilty, J.E., Lorang, D., and Amara, S.G. (1991) Cloning and expression of a cocaine-sensitive rat dopamine transporter. Science 254, 578-579
5. Shimada, S., Kitayama, S., Lin, C.L., Patel, A., Nanthakumar, E., Gregor, P., Kuhar, M., and Uhl, G.R. (1991) Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA. Science 254, 576-578
6. Giros, B., el Mestikawy, S., Godinot, N., Zheng, K., Han, H., Yang-Feng, T., and Caron, M.G. (1992) Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter. Mol. Pharmacol. 42, 383-90
7. Giros, B. and Caron, M.G. (1993) Molecular characterization of the dopamine transporter. Trends Pharmacol. Sci. 14, 43-49
8. Gainetdinov, R.R., Sotnikova, T.D., and Caron, M.G. (2002) Monoamine transporter pharmacology and mutant mice. Trends Pharmacol. Sci. 23, 367-373
9. Madras, B.K., Gracz, L.M., Fahey, M.A., Elmaleh, D., Meltzer, P.C., Liang, A.Y., Stopa, E.G., Babich, J., and Fischman, A.J. (1998) Altropane, a SPECT or PET imaging probe for dopamine neurons: III. Human dopamine transporter in post-mortem normal and Parkinson's diseased brain. Synapse 29, 116-127
10. Muller-Vahl, K.R., Berding, G., Brucke, T., Kolbe, H., Meyer, G.J., Hundeshagen, H., Dengler, R., Knapp, W.H., and Emrich, H.M. (2000) Dopamine transporter binding in Gilles de la Tourette syndrome. J. Neurol. 247, 514-520
11. Krause, K.K., Dresel, S.H., Krause, J., Fougere, C., and Ackenheil, M. (2003) The dopamine transporter and neuroimaging in attention deficit hyperactivity disorder. Neurosci. Biobehav. Rev. 27, 605-613
12. Brunswick, D.J., Amsterdam, J.D., Mozley, P.D., and Newberg, A. (2003) Greater availability of brain dopamine transporters in major depression shown by [99m Tc] TRODAT-1 SPECT imaging. Amer. J. Psychiatry. 160, 1836-1841
13. Giros, B., Jaber, M., Jones, S.R., Wightman, R.M., and Caron, M.G. (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379, 606-612
14. Jaber, M., Dumartin, B., Sagne, C., Haycock, J.W., Roubert, C., Giros, B., Bloch, B., and Caron, M.G. (1999) Differential regulation of tyrosine hydroxylase in the basal ganglia of mice lacking the dopamine transporter. Eur. J. Neurosci. 11, 3499-3511
15. Fauchey, V., Jaber, M., Caron, M.G., Block B., and Moine, C.L. (2000) Differential regulation of the dopamine D1, D2 and D3 receptor gene expression and changes in the phenotype of the striatal neurons in mice lacking the dopamine transporter. Eur. J. Neurosci. 12, 19-26
16. Vandenbergh, D.J., Persico, A.M., Hawkins, A.L., Griffin, C.A., Li, X., Jabs, E.W., and Uhl, G.R. (1992) Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics 14, 1104-1106
17. Cook, Jr. E.H., Stein, M.A., Krasowski, M.D., Cox, N.J., Olkon, D.M., Kieffer, J.E., and Leventhal, B.L. (1995) Association of attention-deficit disorder and dopamine transporter gene. Amer. J. Hum. Genet. 56, 993-998
18. Vandenbergh, D.J., Thompson, M.D., Cook, E.H., Bendahhou, E., Nguyen, T., Krasowski, M.D., Zarrabian, D., Comings, D., Sellers, E.M., Tyndale, R.F., George, S.R., O'Dowd, B.F., and Uhl, G.R. (2000) Human dopamine transporter gene: coding region conservation among normal, Tourette's disorder, alcohol dependence and attention-deficit hyperactivity disorder populations. Mol. Psychiatry 5, 283-292
19. Segman, R.H., Cooper-Kazaz, R., Macciardi, F., Goltser, T., Halfon, Y., Dobroborski, T., and Shalev, A.Y. (2002) Association between the dopamine transporter gene and posttraumatic stress disorder. Mol. Psychiatry 7, 903-907
20. Ueno, S. (2003) Genetic polymorphisms of serotonin and dopamine transporters in mental disorders. J. Med. Invest. 50, 25-31
21. Mitchell, R.J., Howlett, S., Earl, L., White, N.G., McComb, J., Schanfield, M.S., Briceno, I., Papiha, S.S., Osipova, L., Livshits, G., Leonard, W.R., and Crawford, M.H. (2000) Distribution of the 3′ VNTR polymorphism in the human dopamine transporter gene in world populations. Hum. Biol. 72, 295-304
22. Nakamura, Y., Koyama, K., and Matsushima, M. (1998) VNTR (variable number of tandem repeat) sequences as transcriptional, translational, or functional regulators. J. Hum. Genet. 43, 149-152
23. Battersby, S., Ogilvie, A.D., Smith, C.A.D., Blackwood, D.H.R., Muir, W.J., Quinn, J.P., Fink, G., and Harmar, A.J. (1996) Structure of a variable number tandem repeat of the serotonin transporter gene and association with affective disorder. Psychiatr. Genet. 6, 177-181
24. Fiskerstrand, C.E., Lovejoy, E.A., and Quinn, J.P. (1999) An intronic polymorphic domain often associated with susceptibility to affective disorders has allele dependent differential enhancer activity in embryonic stem cells. FEBS Lett. 458, 171-174
25. Mackenzie, A. and Quinn J. (1999) A serotonin transporter gene intron 2 polymorphic region, correlated with affective disorders, has allele-dependent differential enhancer-like properties in the mouse embryo. Proc. Natl. Acad. Sci. USA 96, 15251-15255
26. Heinz, A., Goldman, D., Jones, D.W., Palmour, R., Hommer, D., Gorey, J.G., Lee, K.S., Linnoila, M., and Weinberger, D.R. (2000) Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology 22, 133-139
27. Jacobsen, L.K., Staley, J.K., Zoghbi, S.S., Seibyl, J.P., Kosten, T.R., Innis, R.B., and Gelernter, J. (2000) Prediction of dopamine transporter binding availability by genotype: a preliminary report. Amer. J. Psychiatry. 157, 1700-1703
28. Mill, J., Asherson, P., Browes, C., D'Souza, U., and Craig, I. (2002) Expression of the dopamine transporter gene is regulated by the 3′UTR VNTR: Evidence from brain and lymphocytes using quantitative RT-PCR. Amer. J. Med. Genet. 114, 975-979
29. Fuke, S., Suo, S., Takahashi, N., Koike, H., Sasagawa, N., and Ishiura, S. (2001) The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression. Pharmacogenomics J. 1, 152-156
30. Miller, G.M. and Madras, B.K. (2002) Polymorphisms in the 3′-untranslated region of human and monkey dopamine transporter genes affect reporter gene expression. Mol. Psychiatry 7, 44-55
31. Inoue-Murayama, M., Adachi, S., Mishima, N., Mitani, H., Takenaka, O., Teraco, K., Hayasaka, I., Ito, S., and Murayama, Y. (2002) Variation of variable number of tandem repeat sequences in the 3′-untranslated region of primate dopamine transporter genes that affects reporter gene expression. Neurosci. Lett. 334, 206-210
32. Michelhaugh, S.K., Fiskerstrand, C., Lovejoy, E., Bannon, M.J., and Quinn, J.P. (2001) The dopamine transporter gene (SLC6A3) variable number of tandem repeats domain enhances transcription in dopamine neurons. J. Neurochem. 79, 1033-1038
33. Sacchetti, P., Brownschidle, L.A., Granneman, G.J., and Bannon, M.J. (1999) Characterization of the 5′-flanking region of the human dopamine transporter gene. Brain. Res. Mol. Brain. Res. 74, 167-174
34. Kouzmenko, A.P., Pereira, A.M., and Singh, B.S. (1997) Intronic sequences are involved in neural targeting of human dopamine transporter gene expression. Biochem. Biophys. Res. Commun. 240, 807-811
35. Kokubo, H., Lun, Y., and Johnson, R.L. (1999) Identification and expression of novel family of bHLH cDNAs related to Dorosophila hairy and enhancer of split. Biochem. Biophys. Res. Commun. 260, 459-465
36. Leimeister, C., Externbrink, A., Klamt, B., and Gessler, M. (1999) Hey genes: a novel subfamily of hairy- and Enhancer of split related genes specifically expressed during mouse embryogenesis. Mech. Dev. 85, 173-177
37. Nakagawa, O., Nakagawa, M., Richardson, J.A., Olson, E.N., and Srivastava, D. (1999) HRT1, HRT2, and HRT3: a new subclass of bHLH transcription factors marking specific cardiac, somatic, and pharyngeal arch segments. Dev. Biol. 216, 72-84
38. Iso, T., Kedes, L., and Hamamori, Y. (2003) HES and HERP families: multiple effectors of the Notch signaling pathway. J. Cell Physiol. 194, 237-255
39. Dawson, S.R., Turner, D.L., Weintraub, H., and Parkhurst, S.M. (1995) Specificity for the hairy/enhancer of split basic helix-loop-helix (bHLH) proteins maps outside the bHLH domain and suggests two separable modes of transcriptional repression. Mol. Cell. Biol. 15, 6923-6931
40. Buetow, K.H., Edmonson, M.N., and Cassidy, A.B. (1999) Reliable identification of large numbers of candidate SNPs from EST data. Nat Genet. 21, 323-325
41. Wang, W., Campos, A.M., Prince, C.Z., Mou, Y., and Pollman, M.J. (2002) Coordinate notch3-hairy-related transcription factor pathway regulation in response to arterial injury. J. Biol. Chem. 277, 23165-23171
42. Henderson, A.M., Wang, S.J., Taylor, A.C., Aitkenhead, M., and Hughes, C.C. (2001) The basic helix-loop-helix transcription factor HESR1 regulates endothyelial cell tube formation. J. Biol. Chem. 276, 6169-6176
43. Iso, T., Sartorelli, V., Poizat, C., Iezzi, S., Wu, H.Y., Chung, G., Kedes, L., and Hamamori, Y. (2001) HERP, a novel heterodimer partner of HES/E(spl) in notch signaling. Mol. Cell. Biol. 21, 6080-6089
44. Sakamoto, M., Hirata, H., Ohtsuka, T., Bessho, Y., and Kageyama, R. (2003) The basic helix-loop-helix genes hesr1/ hey1 and hesr2/hey2 regulate maintenance of neural precursor cells in the brain. J. Biol. Chem. 278, 44808-44815
45. Klenova, E., Scott, A.C., Rpberts, J., Shamsuddin, S., Lovejoy, E.A., Bergmann, S., Bubb, V.J., Royer, H.D., and Quinn, J.P. (2004) YB-1 and CTCF differentially regulate the 5-HTT polymorphic intron 2 enhancer which predisposes to a variety of neurological disorders. J. Neurosci. 24, 5966-5973
46. Kamakura, S., Oishi, K., Yoshimatsu, T., Nakafuku, M., Masuyama, N., and Gotoh, Y. (2004) Hes binding to STAT3 mediates crosstalk between Notch and JAK-STAT signaling. Nat. Cell Biol. 6, 547-554
47. Chin, M.T., Maemura, K., Fukumoto, S., Jain, M.K., Layne, M.D., Watanabe, M., Hsieh, C.M., and Lee, M.E. (2000) Cardiovascular basic helix loop helix factor 1, a novel transcriptional represser expressed preferentially in the developing and adult cardiovascular system. J. Biol. Chem. 275, 6381-6387
48. Firulli, B.A., Hadzic, D.B., McDaid, J.R., and Firulli, A.B. (2000) The basic helix-loop-helix transcription factors dHAND and eHand exhibit dimerization characteristics that suggest complex regulation of function. J. Biol. Chem. 275, 33567-33573
49. Xu, H., Firulli, A.B. Zhang, X., and Howard, M.J. (2003) HAND2 synegistically enhances transcription of dopamine-β-hydroxylase in the presence of Phox2a. Dev. Biol. 262, 183-193
50. Rychlik, J.L., Gerbasi, V., and Lewis, E.J. (2003) The interaction between dHAND and Arix at the dopamine-β-hydroxylase promoter region is independent of direct dHAND binding to DNA. J. Biol. Chem. 278, 49652-49660
51. Fisher, A.L. and Caudy, M. (1998) Groucho proteins: transcriptional corepressors for specific subsets of DNA-binding transcription factors in vertebrates and invertebrates. Genes Dev. 12, 1931-1940
52. Basu, S., Nagy, J.A., Pal, S., Vasile, E., Eckelhoefer, I.A., Bliss, V.S., Manseau, E.J., Dasgupta, P.S., Dvorak, H.F., and Mukhopadhyay, D. (2001) The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor. Nat. Med. 7, 569-574
53. Sanchez-Capelo, A., Colin, P., Guibert, B., Biguet, N.F., and Mallet, J. (2003) Transforming growth factor betal overexpression in the nigrostriatal system increases the dopaminergic deficit of MPTP mice. Mol. Cell. Neurosci. 23, 614-625
54. Zavadil, J., Cermak, L., Soto-Nieves, N., and Bottinger, E.P. (2004) Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition. EMBO J. 23, 1155-1165
55. Farkas, L.M., Dunker, N., Roussa, E., Unsicker, K., and Krieglstein, K. (2003) Transforming growth factor-beta(s) are essential for the development of midbrain dopaminergic neurons in vitro and in vivo. J. Neurosci. 23, 5178-5186
56. Stull, N.D., Jung, J.W., and Iacovitti, L. (2001) Induction of a dopaminergic phenotype in cultured striatal neurons by bone morphogenetic proteins. Brain. Res. Dev. Brain. Res. 130, 91-98
57. Dahlqvist, C., Blokzijl, A., Chapman, G., Falk, A., Dannaeus, K., Ibanez, C.F., and Lendahl, U. (2003) Functional Notch signaling is required for BMP4-induced inhibition of myogenic differentiation. Development 130, 6089-6099
58. Takizawa, T., Ochiai, W., Nakashima, K., and Taga, T. (2003) Enhanced gene activation by Notch and BMP signaling cross-talk. Nucleic Acids Res. 31, 5723-5731
59. Fischer, A., Schumacher, N., Maier, M., Sendtner, M., and Gessler, M. (2004) The Notch target genes Hey1 and Hey2 are required for embryonic vascular development. Genes Dev. 18, 901-911